Document Detail


FMRP expression as a potential prognostic indicator in fragile X syndrome.
MedLine Citation:
PMID:  10331602     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Absence or deficit of FMR1 protein (FMRP) resulting from methylation of full mutation genes is the fundamental defect in fragile X syndrome. We used FMRP immunocytochemistry and detailed phenotypic assessment to investigate the relationship between degree of FMRP expression and the broad clinical spectrum of impairment in 80 individuals affected with fragile X syndrome. FMRP expression correlated with IQ in mosaic males (P=0.043), males with a partially methylated full mutation (P=0.0005), and females with a full mutation (P=0.046). In the females, FMRP expression also correlated with the number of fragile X physical features (P=0.0003). Even modest deficits in FMRP result in some manifestations of fragile X syndrome. In this initial study of 53 males, FMRP expression testing had a very high positive predictive value (100%, confidence interval of 29-100%) for a nonretarded IQ among males with expression of FMRP in > or = 50% of lymphocytes (3 males), suggesting that FMRP expression may have potential as a prognostic indicator in males with fragile X syndrome.
Authors:
F Tassone; R J Hagerman; D N Iklé; P N Dyer; M Lampe; R Willemsen; B A Oostra; A K Taylor
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of medical genetics     Volume:  84     ISSN:  0148-7299     ISO Abbreviation:  Am. J. Med. Genet.     Publication Date:  1999 May 
Date Detail:
Created Date:  1999-06-24     Completed Date:  1999-06-24     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  7708900     Medline TA:  Am J Med Genet     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  250-61     Citation Subset:  IM    
Affiliation:
Kimball Genetics Inc., Child Department Unit, The Children's Hospital, Denver, Colorado 80206, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Child
Child, Preschool
DNA / analysis
Female
Fragile X Mental Retardation Protein
Fragile X Syndrome / genetics*
Gene Expression / genetics*
Humans
Immunohistochemistry
Infant
Linear Models
Male
Middle Aged
Mosaicism / genetics
Nerve Tissue Proteins / genetics*
Phenotype
Predictive Value of Tests
Prognosis
RNA-Binding Proteins*
Grant Support
ID/Acronym/Agency:
MCJ-089413//PHS HHS
Chemical
Reg. No./Substance:
0/FMR1 protein, human; 0/Nerve Tissue Proteins; 0/RNA-Binding Proteins; 139135-51-6/Fragile X Mental Retardation Protein; 9007-49-2/DNA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Postmortem examination of two fragile X brothers with an FMR1 full mutation.
Next Document:  Single-strand conformation polymorphism analysis in the FMR1 gene.